Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis (Q38752119)

6 September 2017

title

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis (English)

1 reference

6 September 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

David Moulin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

Brian G. Feagan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

author name string

P Olivera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

J-Y Jouzeau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

P Netter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

S Danese

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

W J Sandborn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

L Peyrin-Biroulet

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

P Emery

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

1 March 2017

1 reference

Alimentary Pharmacology & Therapeutics

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

1058-1072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

Risk estimation in rheumatoid arthritis: from bench to bedside

14 June 2020

cites work

1 reference

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 January 2018

1 reference

Surgery for adult Crohn's disease: what is the actual risk?

21 January 2018

1 reference

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

21 January 2018

1 reference

Treating rheumatoid arthritis to target: recommendations of an international task force

21 January 2018

1 reference

Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study

21 January 2018

1 reference

Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments

21 January 2018

1 reference

Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

21 January 2018

1 reference

EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis

21 January 2018

1 reference

After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?

21 January 2018

1 reference

Adalimumab induces deep remission in patients with Crohn's disease.

21 January 2018

1 reference

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

21 January 2018

1 reference

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

21 January 2018

1 reference

An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials.

21 January 2018

1 reference

Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study

21 January 2018

1 reference

Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients

21 January 2018

1 reference

Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort

21 January 2018

1 reference

Development of the Crohn's disease digestive damage score, the Lémann score

21 January 2018

1 reference

Preventing Collateral Damage in Crohn's Disease: The Lémann Index

21 January 2018

1 reference

Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.

21 January 2018

1 reference

Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Asse

21 January 2018

1 reference

Measurement of patient outcome in arthritis

21 January 2018

1 reference

ICF Core Sets for rheumatoid arthritis

21 January 2018

1 reference

Validation of the Comprehensive ICF Core Set for rheumatoid arthritis: the perspective of psychologists

21 January 2018

1 reference

Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups.

21 January 2018

1 reference

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

21 January 2018

1 reference

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

21 January 2018

1 reference

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

Impact of inflammatory bowel disease on health-related quality of life

21 January 2018

1 reference

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease

21 January 2018

1 reference

Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

21 January 2018

1 reference

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

21 January 2018

1 reference

Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.

21 January 2018

1 reference

Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients

21 January 2018

1 reference

Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis

21 January 2018

1 reference

Physical and Mental Functioning in Patients with Established Rheumatoid Arthritis over an 11-year Followup Period: The Role of Specific Comorbidities

21 January 2018

1 reference

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

21 January 2018

1 reference

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

21 January 2018

1 reference

The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials

21 January 2018

1 reference

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

21 January 2018

1 reference

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis

21 January 2018

1 reference

Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study.

21 January 2018

1 reference

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

21 January 2018

1 reference

Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis

21 January 2018

1 reference

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

21 January 2018

1 reference

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

21 January 2018

1 reference

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

21 January 2018

1 reference

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

21 January 2018

1 reference

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

21 January 2018

1 reference

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

21 January 2018

1 reference

Deep remission: a new concept?

21 January 2018

1 reference

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis

21 January 2018

1 reference

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

21 January 2018

1 reference

Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases

21 January 2018

1 reference

Early undifferentiated arthritis.

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

21 January 2018

1 reference

Drug management of early rheumatoid arthritis - 2008.

21 January 2018

1 reference

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

21 January 2018

1 reference

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

21 January 2018

1 reference

What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review

21 January 2018

1 reference

Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics

21 January 2018

1 reference

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

21 January 2018

1 reference

The immunology of mucosal models of inflammation

21 January 2018

1 reference

Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease

21 January 2018

1 reference

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

21 January 2018

1 reference

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

21 January 2018

1 reference

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

21 January 2018

1 reference

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

21 January 2018

1 reference

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

21 January 2018

1 reference

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

21 January 2018

1 reference

Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs

21 January 2018

1 reference

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature

21 January 2018

1 reference

Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial

21 January 2018

1 reference

Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.

21 January 2018

1 reference

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

21 January 2018

1 reference

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

21 January 2018

1 reference

Clinical risk factors for complicated disease: how reliable are they?

21 January 2018

1 reference

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind

21 January 2018

1 reference

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease

21 January 2018

1 reference

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

21 January 2018

1 reference

Development of an index to define overall disease severity in IBD.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.13995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 June 2020

Altmetric DOI

10.1111/APT.13995

0 references

1084210301

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247573 AND SRC:MED&resulttype=core&format=json